DRUG STUDY

Generic Brand General Mode of action Indication Contraindication Usual dose Actual dose Side effects Nursing responsibilities
name name classification

C C 2nd generation Inhibits bacterial For bacterial Hypersensitivity to 750mg 750mg IVTT q8 INTEG: rash, pruritis ASSESS:
E E cephalosporin cell wall synthesis, infection, serious cephalosporins or IVTT q8 hours ANST (-)
F F rendering cell wall lower respiratory related antibiotics, hours GI: nausea, vomiting Nephrotoxicity: increased
U T osmotically tract, urinary tract, seizures. diarrhea, GI discomfort BUN, creatinine
R I unstable, leading to skin, bone, joint,
O N cell death by gonococcal HEMA: epistaxis, purpura I and O
X binding to cell wall infections,
I membrane. septicemia, CV: edema, hypertension Urine output:if decreased it
M meningitis. may indicate nephrotoxicity
E CNS: headache, dizziness
Allergic reactions: rash,
MS: arthralgia, back pain flushing, urticaria, pruritis

RESP: upper respiratory For 10-14 days to ensure

tract infection, dyspnea, organism death, prevent
rhinitis, bronchitis, cough superinfection.

MISC: UTI, depression, With food if needed for GI

hypercholesterolemia, symptoms.
chest pain, fatigue,
intracranial hemorrhage.
 DRUG STUDY
Generic Brand General Mode of action Indication Contraindication Usual dose Actual dose Side effects Nursing responsibilities
name name classification

D V Non-steroidal Inhibits Acute,chronic Hypersensitivity to 75 mg by 1amp 1G now GI: nausea, anorexia, Teach client;
I O anti prostaglandin rheumatoid arthritis, aspirin, iodides, deep OD vomiting, diarrhea,
C L inflammatory synthesis by osteoarthritis; other non-steroidal intragluteal jaundice, cholestatic To report bleeding, bruising,
L T decreasing ankylosing anti inflammatory injection hepatitis, constipation, fatigue, malaise, blood
O A enzyme needed spondylitis, agents, asthma. once daily, hepatotoxicity. dyscrasias do occur.
F R for analgesia, primary or two
E E biosynthesis; dysmenorrhea, times per CNS: Dizziness, Headache, To take with food, milk or
N N Analgesic, anti ophth, postoperative day in drowsiness, fatigue, antacids to avoid GI upset.
A inflammatory, inflammation after tremors, confusion,
severe or
C antipyretic cataract extraction. insomnia. To take with a full glass of
hospitalize
water to enhance absorption.
S d cases. CV: CHF, tachycardia,
O peripheral edema, To use sunscreen to prevent
D palpitation, dysrythmias, photosensitivity.
I hypotension.
U To report hepatotoxicity; flu
M INTEG: Purpura, rash, symptoms, nausea vomiting,
pruritus, sweating, jaundice, pruritus, lethargy.
erythema, petechiae.

GU: Nephrotoxicity,
Dysuria, hematuria,

EENT: Tinnitus, hearing

loss, blurring of vision.
 DRUG STUDY
Generic Brand General Mode of action Indication Contraindication Usual dose Actual dose Side effects Nursing responsibilities
name name classification

F L Loop Diuretic Inhibits the Edema due to: Hypersensitivity Adults: 20mg IVTT now CNS: dizziness, Teach client;
U A reabsorption of sodium CHF, hepatic or to sulfonamides, 20-40mg encephalic, headache,
R S and chloride from the renal disease, anuria, IVTT insomnia, nervousness. To rise slowly from lying or
O I loop of henle and distal hypertension. hypovolemia, increase by sitting position: orthostatic
S X renal tubule. Increase infants, lactation, 20mg q2h EENT: hearing loss, hypotension may occur.
E renal excretion of electrolyte until desired tinnitus.
M water, sodium, chloride, depletion. response. To take with food or milk for
I magnesium, hydrogen CV: hypertension, GI symptoms.
D and calcium. May have circulatory collapse.
E renal and peripheral To use sunscreen or
vasodilatory GI: constipation, protective clothing.
Effects. diarrhea, dry mouth,
dyspepsia, nausea and To recognize adverse
vomiting. reaction that may occur;
muscle cramps, weakness,
GU: excessive nausea, dizziness.
urination, renal failure,
glycosuria. To take early in day to
prevent sleeplessness.
HEMA: blood
dyscrasia,
thrombocytopenia,
agranulocytosis, anemia
 DRUG STUDY
Generic Brand General Mode of action Indication Contraindication Usual dose Actual dose Side effects Nursing responsibilities
name name classification

H B Inhibits treatment of Contraindicated in 10-20mg Buscopan CNS: disorientation, IV use: keep in mind that
Y U Anticholinergics muscarinic gastric ulcer, patients with IVTT tid or IVTT now restlessness, irritability, intermittent and continuous
O S Antispasmodics actions of duodenal ulcer, Angle-closure qid. 1amp dizziness, drowsiness, infusions are not
S C acetylcholine gastritis, glaucoma, headache, confusion. recommended.
C O on autonomic duodenitis and obstructive
I P effectors intestinal & uropathy, CV: palpitations, Protect IV solutions from
N A innervated by cholelithic colic. obstructive disease tachycardia, paradoxical freezing and light, and store at
E N postganglionic For relief of of the GI tract, bradycardia. room temperature.
cholinergic biliary spasm. For asthma, chronic
N neurons. relief of urinary pulmonary disease, EENT: dilated pupils, Raise the beds side rails as a
tract spasm. myasthenia gravis, blurred vision, photophobia, precaution because some
B paralytic ileus, increased intraocular patients become temporarily
U intestinal atony, pressure, difficulty excited or disoriented.
T unstable swallowing. Symptoms disappear when
Y cardiovascular sedative effect complete.
L status in acute GI: constipation, dry
hemorrhage or mouth, nausea vomiting, Alert the patient to the
B toxic megacolon. epigastric distress. possibility of withdrawal
R symptoms (nausea, vomiting,
O GU: urinary hesitancy, headache, dizziness) if the
M urine retention. transdermal system is used
I longer than 72hours.
D SKIN: rash, flushing,
E dryness, contact dermatitis. Advise patient to report signs
of urinary hesitancy or urine
retention.
 DRUG STUDY

Generic Brand General Mode of action Indication Contraindication Usual dose Actual dose Side effects Nursing responsibilities
name name classification

M M enolic acid group of inhibits Relief of the signs Contraindicated in Starting 7.5mg/tab 1tab CNS: Headache, dizziness, Administer drug with food
E O nonsteroidal anti- cyclooxygenase and symptoms of patients with dose, 7.5 mg q12h prn for somnolence, insomnia, or milk if GI upset occurs.
L B inflammatory drugs (COX), the osteoarthritis and known PO daily. pain fatigue, tiredness, dizziness,
O I enzyme rheumatoid hypersensitivity to Maximum tinnitus. Establish safety measures if
X C responsible for arthritis. meloxicam. It dosage, 15 Dermatologic: Rash, CNS disturbances occur.
I converting should not be given mg PO pruritus, sweating, dry
C arachidonic to patients who daily. mucous membranes Monitor patient on
A acid into have experienced GI: Nausea, dyspepsia, GI prolonged therapy for signs
M prostaglandin asthma, urticaria, pain, diarrhea, vomiting, of GI bleeding or hepatic
H2—the first or allergic-type constipation, flatulence toxicity.
step in the reactions after GU: Dysuria, renal
synthesis of taking aspirin or impairment You may experience these
prostaglandins, other NSAIDs. Hematologic: Bleeding, side effects: Dizziness,
which are Severe, rarely fatal, platelet inhibition (with drowsiness (avoid driving or
mediators of anaphylactic-like higher doses), neutropenia, using dangerous machinery
inflammation reactions to eosinophilia, leukopenia, while taking this drug).
NSAIDs have been pancytopenia,  
reported in such thrombocytopenia,
patients. decreased hemoglobin or
hematocrit, bone marrow Advice patient to Report
depression. sore throat, fever, rash,
Respiratory: Dyspnea, itching, weight gain,
hemoptysis, pharyngitis. swelling in ankles or fingers,
changes in vision, black,
tarry stools.
Other: Peripheral edema,
anaphylactoid reactions to
anaphylactic shock. Provide further comfort
measures to reduce pain
(positioning, environmental
control), and to reduce
inflammation (warmth,
positioning, rest).

DRUG STUDY
Generic Brand General Mode of action Indication Contraindication Usual dose Actual dose Side effects Nursing responsibilities
name name classification

Branched A Parenteral a group of essential Improvement of contraindicated in 500 mL-1 Aminoleban Hypersensitivity: rare skin Since elderly patients
chain M Nutritional amino acids that play the nutritional patients with L/day by 500cc x 12h eruptions. If often have reduced
amino I product state of chronic severe renal drip IV hypersensitivity reactions physiological function, it is
important roles in
acid N hepatic impairment and infusion; occur, the solution should advisable to take
O protein synthesis and such measures as
insufficiency abnormal amino 500 mL over be discontinued.
L energy production. reducing the dose by
patients including acid metabolism 180-300
E those with hepatic other than min. Gastrointestinal: decreasing the infusion.
B encephalopathy hepatic disorders. occasional nausea and
A If the patient develops
vomiting.
N hypoglycemia, glucose
should be administered
Cardiovascular: occasional promptly by intravenous
chest discomfort and infusion. In addition,
palpitation. appropriate nutrition
management is
Others: occasional chills, recommended in such
fever, headache and patients.
vascular pain.
If adverse reactions are
observed, discontinue the
administration, and
institute appropriate
treatment.

DRUG STUDY
Generic Brand General Mode of action Indication Contraindication Usual dose Actual dose Side effects Nursing responsibilities
name name classification

C U Digestive Unknown. Probably Dissolution of Pt with Adult: 250mg/cap GI: Diarrhea, cramps, Be aware that treatment
H R enzymes and suppresses hepatic radiolucent hepatocyte 250mg PO 1cap tid heartburn, constipation, should be reserved for
S synthesis of both cholesterol nausea, vomiting, anorexia, carefully selected
E gallstone dysfunction, bid for the
O cholesterol and cholic acid. stones(gallstones) epigastric distress. patients.
N F solubilizer These actions contribute to when systemic intrahepatic first 2
O A biliary cholesterol disease or age cholestasis, weeks, Hepatic: reversible
D L desaturation and gradual precludes surgery. primary biliary followed, elevated hepatic enymes, Know that the drug is
E K dissolution of gallstones. cirrhosis, or as possible liver toxicity. particularly effective in the
O sclerosing tolerated, dissolution of small,
floatable gallstones.
X cholangitis. by weekly
Y Gallstone increases
C complication or of Encourage compliance
H compelling 250mg/day with the prescribed drug
O reasons for , up to 13 regimen and with
L gallbladder to 16 scheduled follow up
appointments.
I surgery. mg/kg/day
C Gallstone for up to
induced 24 months. Tell client to immediately
A pancreatitis, report worsening
C biliary fistula, symptoms, such as
I and in sudden right upper
quadrant pain, nausea,
D pregnancy.
and vomiting.